UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 98

Sortiert nach

Chronic Thromboembolic Pulmonary Hypertension

Journal of the American College of Cardiology, 2013-12, Vol.62 (25), p.D92-D99

2013

Volltextzugriff (PDF)

Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2018-02, Vol.18 (1), p.1-11

2018

Volltextzugriff (PDF)

Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension

Journal of the American College of Cardiology, 2008-12, Vol.52 (25), p.2127-2134

2008

Volltextzugriff (PDF)

Chronic thromboembolic pulmonary hypertension: role of medical therapy

The European respiratory journal, 2013-04, Vol.41 (4), p.985-990

2013

Volltextzugriff (PDF)

Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)

Chest, 2014-11, Vol.146 (5), p.1274-1285

2014

Volltextzugriff (PDF)

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension

PloS one, 2021-01, Vol.16 (1), p.e0245752-e0245752

2021

Volltextzugriff (PDF)

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

PloS one, 2018-03, Vol.13 (3), p.e0193226-e0193226

2018

Volltextzugriff (PDF)

Prediction Score for persisting perfusion defects after pulmonary embolism

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2020-12, Vol.164 (4), p.394-400

2020

Volltextzugriff (PDF)

The impact of riociguat on clinical parameters and quality of life in patients with chronic thromboembolic pulmonary hypertension - results of a retrospective clinical registry

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2021-06, Vol.165 (2), p.157-161

2021

Volltextzugriff (PDF)

Computed tomography angiographic parameters of pulmonary artery as prognostic factors of residual pulmonary hypertension after pulmonary endarterectomy

Journal of international medical research, 2021-03, Vol.49 (3), p.3000605211002024-3000605211002024

2021

Volltextzugriff (PDF)

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension

Chest, 2017-01, Vol.151 (1), p.106-118

2017

Volltextzugriff (PDF)

PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

Orphanet journal of rare diseases, 2021-05, Vol.16 (1), p.196-196, Article 196

2021

Volltextzugriff (PDF)

Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications

Medicina (Kaunas, Lithuania), 2022-10, Vol.58 (11), p.1538

2022

Volltextzugriff (PDF)

Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients

International journal of cardiology, 2014-03, Vol.172 (2), p.332-339

2014

Volltextzugriff (PDF)

Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)

Pulmonary circulation, 2020-07, Vol.10 (3), p.1-10

2020

Volltextzugriff (PDF)

Reperfusion after pulmonary embolism - long-term follow-up, risk factors, clinical impact

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2018-06, Vol.162 (2), p.121-126

2018

Volltextzugriff (PDF)

Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension: Impact on Clinical and Hemodynamic Parameters, Quality of Life and Risk Profile

Journal of clinical medicine, 2020-11, Vol.9 (11), p.3608

2020

Volltextzugriff (PDF)

Correction: Jansa et al. Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension. J. Clin. Med. 2022, 11 , 6189

Journal of clinical medicine, 2023-06, Vol.12 (12), p.3939

2023

Volltextzugriff (PDF)

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil

Pulmonary circulation, 2023-07, Vol.13 (3), p.e12274-e12274

2023

Volltextzugriff (PDF)

Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic

Pulmonary circulation, 2022-01, Vol.12 (1), p.e12038-n/a

2022

Volltextzugriff (PDF)

Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension

Journal of clinical medicine, 2022-10, Vol.11 (20), p.6189

2022

Volltextzugriff (PDF)

Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice

Pulmonary circulation, 2020-01, Vol.10 (1), p.1-11

2020

Volltextzugriff (PDF)

Residual pulmonary hypertension after pulmonary endarterectomy: A meta-analysis

The Journal of thoracic and cardiovascular surgery, 2018-09, Vol.156 (3), p.1275-1287

2018

Volltextzugriff (PDF)

COVID-19 in disorders of pulmonary circulation

Cor et vasa (English ed.), 2020-06, Vol.62 (Suppl.1), p.19-21

2020

Volltextzugriff (PDF)

Long-term Riociguat Treatment in Inoperable and Persistent/Recurrent CTEPH Patients in WHO Functional Class (FC) I/II Versus FC III/IV at Baseline: Results From the 16-Week Phase III CHEST-1 Study and CHEST-2 Open-Label Extension

Chest, 2014-03, Vol.145 (3), p.535B-1-535B-3

2014

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(92)
Tagungsberichte
(6)

Sprache

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Chronic Thromboembolic Pulmonary Hypertension

Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial

Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension: role of medical therapy

Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

Prediction Score for persisting perfusion defects after pulmonary embolism

The impact of riociguat on clinical parameters and quality of life in patients with chronic thromboembolic pulmonary hypertension - results of a retrospective clinical registry

Computed tomography angiographic parameters of pulmonary artery as prognostic factors of residual pulmonary hypertension after pulmonary endarterectomy

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension

PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications

Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients

Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)

Reperfusion after pulmonary embolism - long-term follow-up, risk factors, clinical impact

Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension: Impact on Clinical and Hemodynamic Parameters, Quality of Life and Risk Profile

Correction: Jansa et al. Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension. J. Clin. Med. 2022, 11 , 6189

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil

Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic

Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension

Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice

Residual pulmonary hypertension after pulmonary endarterectomy: A meta-analysis

COVID-19 in disorders of pulmonary circulation

Long-term Riociguat Treatment in Inoperable and Persistent/Recurrent CTEPH Patients in WHO Functional Class (FC) I/II Versus FC III/IV at Baseline: Results From the 16-Week Phase III CHEST-1 Study and CHEST-2 Open-Label Extension

Aktive Filter

Suchergebnisse filtern